291 related articles for article (PubMed ID: 15153842)
1. Immunotherapeutic strategies for malignant glioma.
Fenstermaker RA; Ciesielski MJ
Cancer Control; 2004; 11(3):181-91. PubMed ID: 15153842
[TBL] [Abstract][Full Text] [Related]
2. Novel immunotherapeutic approaches to glioma.
Yamanaka R
Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
[TBL] [Abstract][Full Text] [Related]
3. Cell- and peptide-based immunotherapeutic approaches for glioma.
Yamanaka R
Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell immunotherapy for malignant gliomas.
Luptrawan A; Liu G; Yu JS
Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
[TBL] [Abstract][Full Text] [Related]
5. [Dendritic cell therapy for malignant glioma].
Yamanaka R; Homma J; Yajima N; Tsuchiya N; Tanaka R
No To Shinkei; 2003 Sep; 55(9):771-80. PubMed ID: 14571839
[TBL] [Abstract][Full Text] [Related]
6. Peptide-based immunotherapeutic approaches to glioma: a review.
Yamanaka R; Itoh K
Expert Opin Biol Ther; 2007 May; 7(5):645-9. PubMed ID: 17477802
[TBL] [Abstract][Full Text] [Related]
7. Dendritic-cell- and peptide-based vaccination strategies for glioma.
Yamanaka R
Neurosurg Rev; 2009 Jul; 32(3):265-73; discussion 273. PubMed ID: 19214609
[TBL] [Abstract][Full Text] [Related]
8. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.
Zhu X; Lu C; Xiao B; Qiao J; Sun Y
J Neurooncol; 2005 Aug; 74(1):9-17. PubMed ID: 16078102
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for malignant glioma: current approaches and future directions.
Sikorski CW; Lesniak MS
Neurol Res; 2005 Oct; 27(7):703-16. PubMed ID: 16197807
[TBL] [Abstract][Full Text] [Related]
10. [Cellular immunotherapy for malignant glioma].
Okamoto Y; Yamashita J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
[No Abstract] [Full Text] [Related]
11. Dendritic cell-based immunotherapy for malignant gliomas.
Akasaki Y; Black KL; Yu JS
Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.
Prins RM; Odesa SK; Liau LM
Cancer Res; 2003 Dec; 63(23):8487-91. PubMed ID: 14679014
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells.
De Vleeschouwer S; Van Gool SW; Van Calenbergh F
Childs Nerv Syst; 2005 Jan; 21(1):7-18. PubMed ID: 15452731
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.
Wang X; Zhao HY; Zhang FC; Sun Y; Xiong ZY; Jiang XB
Cancer Invest; 2014 Nov; 32(9):451-7. PubMed ID: 25259676
[TBL] [Abstract][Full Text] [Related]
15. Cytokine gene therapy for malignant glioma.
Okada H; Pollack IF
Expert Opin Biol Ther; 2004 Oct; 4(10):1609-20. PubMed ID: 15461572
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials.
Ehtesham M; Black KL; Yu JS
Cancer Control; 2004; 11(3):192-207. PubMed ID: 15153843
[TBL] [Abstract][Full Text] [Related]
17. T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.
Akasaki Y; Black KL; Yu JS
Front Biosci; 2005 Sep; 10():2908-21. PubMed ID: 15970545
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
Pollack IF; Okada H; Chambers WH
Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.
Yang L; Ng KY; Lillehei KO
Cancer Control; 2003; 10(2):138-47. PubMed ID: 12712008
[TBL] [Abstract][Full Text] [Related]
20. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
